Associations of Sex Steroids and Sex Hormone-Binding Globulin with Non-Alcoholic Fatty Liver Disease: A Population-Based Study and Meta-Analysis

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2022 Jun 24

PMID 35741728

Authors

Xiaofang Zhang

Yuchan Mou

Elif Aribas

Masoud Amiri

Jana Nano

Wichor M Bramer

Maryam Kavousi

Robert J de Knegt

Eralda Asllanaj

Mohsen Ghanbari

Affiliations

Soon will be listed here.

Abstract

Background: Prior studies have reported inconsistent results or less well-explored associations between sex hormones and non-alcoholic fatty liver disease (NAFLD). Here, we aimed to investigate the associations of NAFLD with sex steroids and sex hormone-binding globulin (SHBG) in the population-based study and conduct a comprehensive systematic review and meta-analysis of all published observational studies.

Methods: Analyses included 755 men and 1109 women with available data on sex steroids, SHBG, and ultrasound-based NAFLD from the Rotterdam Study. Multivariable regression models were used to examine the associations. Additionally, we searched five databases from inception to 1 April 2022 and performed a systematic review and meta-analysis. Random-effects (DerSimonian-Laird) method was used for meta-analysis, odds ratios (ORs) were calculated for the effect estimate, subgroup and leave-one-out sensitivity analyses were conducted, and meta-regression was performed to explore the pooled statistics with high heterogeneity.

Results: In the Rotterdam Study, lower levels of SHBG were associated with NAFLD in both sexes, while lower testosterone was associated with NAFLD only among women. Similarly, the meta-analysis of 16 studies indicated no sex-specific association between SHBG and NAFLD (men: OR = 0.37, 95%CI 0.21-0.53; women: OR = 0.40, 95%CI 0.21-0.60), yet there was a sex-specific association between testosterone and NAFLD (men: OR = 0.59, 95%CI 0.42-0.76; women: OR = 1.06, 95%CI 0.68-1.44). Moreover, men with NAFLD had lower estradiol levels than those without NAFLD.

Conclusions: Lower SHBG levels were associated with NAFLD in both sexes, but testosterone levels were associated in a sex-specific manner. In addition, our results showed estradiol with the potential as a protective factor for NAFLD in healthy men.

Citing Articles

The relationship between follicle-stimulating hormone and metabolic dysfunction-associated fatty liver disease in men.

Bin D, Liu F, Peng K, Zhan M, Tan Y, Liu Q Nutr Diabetes. 2024; 14(1):52.

PMID: 38991999 PMC: 11239811. DOI: 10.1038/s41387-024-00314-1.

Associations of sex-related and thyroid-related hormones with risk of metabolic dysfunction-associated fatty liver disease in T2DM patients.

Lu W, Li S, Li Y, Zhou J, Wang K, Chen N BMC Endocr Disord. 2024; 24(1):84.

PMID: 38849804 PMC: 11161932. DOI: 10.1186/s12902-024-01618-0.

Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses.

Cao M, Cui B Cardiovasc Diabetol. 2024; 23(1):126.

PMID: 38614964 PMC: 11016216. DOI: 10.1186/s12933-024-02222-1.

Sex-specific differences in ectopic fat and metabolic characteristics of paediatric nonalcoholic fatty liver disease.

Lee E, Kim J, Yang H Int J Obes (Lond). 2023; 48(4):486-494.

PMID: 38114813 DOI: 10.1038/s41366-023-01439-6.

Association of sex hormones and sex hormone-binding globulin with liver fat in men and women: an observational and Mendelian randomization study.

Cai X, Thorand B, Hohenester S, Prehn C, Cecil A, Adamski J Front Endocrinol (Lausanne). 2023; 14:1223162.

PMID: 37900132 PMC: 10611498. DOI: 10.3389/fendo.2023.1223162.

References

Muller M, Grobbee D, Tonkelaar I, Lamberts S, van der Schouw Y . Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005; 90(5):2618-23. DOI: 10.1210/jc.2004-1158. View

Lazo M, Zeb I, Nasir K, Tracy R, Budoff M, Ouyang P . Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis. Clin Gastroenterol Hepatol. 2015; 13(9):1686-93.e2. PMC: 4500744. DOI: 10.1016/j.cgh.2014.12.033. View

Younossi Z . Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2018; 70(3):531-544. DOI: 10.1016/j.jhep.2018.10.033. View

Seo N, Koo H, Haam J, Kim H, Kim M, Park K . Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone. J Gastroenterol Hepatol. 2015; 30(7):1211-6. DOI: 10.1111/jgh.12935. View

Chalasani N, Younossi Z, Lavine J, Charlton M, Cusi K, Rinella M . The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2017; 67(1):328-357. DOI: 10.1002/hep.29367. View

Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward H, Johnson L . Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014; 160(6):398-406. DOI: 10.7326/M13-1788. View

Eslam M, Newsome P, Sarin S, Anstee Q, Targher G, Romero-Gomez M . A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020; 73(1):202-209. DOI: 10.1016/j.jhep.2020.03.039. View

Charlton M, Angulo P, Chalasani N, Merriman R, Viker K, Charatcharoenwitthaya P . Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology. 2008; 47(2):484-92. PMC: 2906146. DOI: 10.1002/hep.22063. View

Sarkar M, Yates K, Suzuki A, Lavine J, Gill R, Ziegler T . Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men. Clin Gastroenterol Hepatol. 2019; 19(2):400-402.e2. PMC: 7272262. DOI: 10.1016/j.cgh.2019.11.053. View

10.

Chalasani N, Younossi Z, Lavine J, Diehl A, Brunt E, Cusi K . The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012; 55(6):2005-23. DOI: 10.1002/hep.25762. View

11.

Li L, Yao Y, Zhao J, Cao J, Ma H . Dehydroepiandrosterone protects against hepatic glycolipid metabolic disorder and insulin resistance induced by high fat via activation of AMPK-PGC-1α-NRF-1 and IRS1-AKT-GLUT2 signaling pathways. Int J Obes (Lond). 2020; 44(5):1075-1086. DOI: 10.1038/s41366-019-0508-8. View

12.

Gross B, Pawlak M, Lefebvre P, Staels B . PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol. 2016; 13(1):36-49. DOI: 10.1038/nrendo.2016.135. View

13.

Lee C, Kim J, Jung Y . Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Cells. 2019; 8(10). PMC: 6835656. DOI: 10.3390/cells8101259. View

14.

Ayonrinde O, Adams L, Doherty D, Mori T, Beilin L, Oddy W . Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys. J Gastroenterol Hepatol. 2015; 31(5):980-7. DOI: 10.1111/jgh.13241. View

15.

Zelber-Sagi S, Lotan R, Shlomai A, Webb M, Harrari G, Buch A . Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol. 2012; 56(5):1145-1151. DOI: 10.1016/j.jhep.2011.12.011. View

16.

Mousavinasab F, Tahtinen T, Jokelainen J, Koskela P, Vanhala M, Oikarinen J . The Pro12Ala polymorphism of the PPAR gamma 2 gene influences sex hormone-binding globulin level and its relationship to the development of the metabolic syndrome in young Finnish men. Endocrine. 2007; 30(2):185-90. DOI: 10.1385/ENDO:30:2:185. View

17.

Shin J, Kim S, Lee M, Kim H, Ye B, Shin Y . Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes. Diabetes Res Clin Pract. 2011; 94(1):156-62. DOI: 10.1016/j.diabres.2011.07.029. View

18.

Wong V, Wong G, Yeung D, Lau T, Chan C, Chim A . Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. J Hepatol. 2014; 62(1):182-9. DOI: 10.1016/j.jhep.2014.08.041. View

19.

Muka T, Nano J, Jaspers L, Meun C, Bramer W, Hofman A . Associations of Steroid Sex Hormones and Sex Hormone-Binding Globulin With the Risk of Type 2 Diabetes in Women: A Population-Based Cohort Study and Meta-analysis. Diabetes. 2017; 66(3):577-586. DOI: 10.2337/db16-0473. View

20.

Sarkar M, VanWagner L, Terry J, Carr J, Rinella M, Schreiner P . Sex Hormone-Binding Globulin Levels in Young Men Are Associated With Nonalcoholic Fatty Liver Disease in Midlife. Am J Gastroenterol. 2019; 114(5):758-763. PMC: 6599461. DOI: 10.14309/ajg.0000000000000138. View